Skip to content
Home/Companies/Biotech/Acousia Therapeutics
Acousia Therapeutics

Acousia Therapeutics

Biotech·Germany·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Acousia Therapeutics?

Acousia Therapeutics is a German Biotech company, currently owned by LBBW Venture Capital since 2018 and 2 other investors.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Creathor Ventures
Most recent investor
Creathor Ventures
Creathor Venture Fund IV · 2018 · Evergreen
3 ownership periods · full history below

Key facts

HQGermany
SectorBiotech
StatusActive

Ownership history

3 ownership periods · co-invest detected

Co-invest · 3 holders · 2012 · present
Boehringer Ingelheim Venture Fund
2012 · present(14yr) · Boehringer Ingelheim Venture Fund · 2010 · Evergreen
Creathor Ventures
2018 · present(8yr) · Creathor Venture Fund IV · 2018 · Evergreen
LBBW Venture Capital
2018 · present(8yr) · LBBW VC Evergreen Vehicle · 1998 · VC

Questions

Who owns Acousia Therapeutics?

Acousia Therapeutics is currently owned by LBBW Venture Capital, Creathor Ventures and 1 other, through Creathor Venture Fund IV, since 2018.

When did LBBW Venture Capital and 2 others acquire Acousia Therapeutics?

LBBW Venture Capital and 2 others acquired Acousia Therapeutics in 2018.

Who has owned Acousia Therapeutics over time?

Acousia Therapeutics has been through 3 private-equity ownership periods: Boehringer Ingelheim Venture Fund · via Boehringer Ingelheim Venture Fund · since 2012; LBBW Venture Capital · via LBBW VC Evergreen Vehicle · since 2018; Creathor Ventures · via Creathor Venture Fund IV · since 2018.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue